The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

They exhibit remarkable sensitivity, wide dynamic range and robust performance that compares advantageously with conventional enzyme-linked immunosorbent assay (ELISA). ELISA is the most widely ...

Recent study conducted by Caushi et al. aimed to evaluate the role of Elisa IgG serum antibody titres in diagnosing pulmonary ...